Literature DB >> 6266641

Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong.

C L Lai, K C Lam, K P Wong, P C Wu, D Todd.   

Abstract

A retrospective study of 211 patients with proven hepatocellular carcinoma (HCC) was made. The commonest symptoms were anorexia and malaise (73%). Five patients (2.5%) had near-normal biochemical tests despite the presence of massive tumors. Diagnostic yield from angiography, percutaneous peritoneoscopic biopsy, or scintiscanning was 87-98%. Three percent of the patients had resectable tumors. Median survival for patients with untreated disease was 3.5 weeks. Apart from histology, the total serum bilirubin level was the only factor of prognostic value. Only 12 patients had preexisting symptomatic cirrhosis. When compared with 80 patients with symptomatic postnecrotic cirrhosis without malignancy, patients with HCC had higher SGOT:SGPT ratio, Higher serum albumin levels, and higher platelet counts. There was only minimal overlap of patients with symptomatic postnecrotic cirrhosis and those with HCC. The authors conclude that their patients with HCC appeared late for treatment. A probable difference in the development of symptomatic postnecrotic cirrhosis and of HCC with asymptomatic postnecrotic cirrhosis is suggested.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6266641     DOI: 10.1002/1097-0142(19810601)47:11<2746::aid-cncr2820471134>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  24 in total

1.  Cutaneous and colonic metastases after resection of hepatocellular carcinoma.

Authors:  Masaki Kaibori; Mika Morita; Shuuji Tagami; Yoichiro Uchida; Hironori Tanaka; Kazuhiko Yoshioka; Yu Takahashi; Noriko Sakaida; Yoshiko Uemura; Toshihito Seki; Kazuichi Okazaki; Yasuo Kamiyama
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

2.  Treatment of unresectable hepatocellular carcinoma: results of a randomized controlled trial.

Authors:  E C Lai; T K Choi; S W Tong; G B Ong; J Wong
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

Review 3.  The role of cirrhosis in the etiology of hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  J Gastrointest Cancer       Date:  2014-03

4.  Clinical decision analysis using microcomputers. A case of coexistent hepatocellular carcinoma and abdominal aortic aneurysm.

Authors:  J B Wong; A J Moskowitz; S G Pauker
Journal:  West J Med       Date:  1986-12

Review 5.  Screening for hepatocellular carcinoma. Review and perspective.

Authors:  J C Ellis
Journal:  West J Med       Date:  1988-08

6.  Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis.

Authors:  T Nagao; S Inoue; S Goto; T Mizuta; Y Omori; N Kawano; Y Morioka
Journal:  Ann Surg       Date:  1987-01       Impact factor: 12.969

7.  Clinical predictors of large esophagogastric varices in patients with hepatocellular carcinoma.

Authors:  Jun-Lin Yeh; Yen-Chun Peng; Chun-Fang Tung; Gran-Hum Chen; Wai-Keung Chow; Chi-Sen Chang; Hong-Zen Yeh; Sek-Kwong Poon
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

8.  Fibrosis in non-cancerous tissue is the unique prognostic factor for primary hepatocellular carcinoma without hepatitis B or C viral infection.

Authors:  Yoshito Tomimaru; Yo Sasaki; Terumasa Yamada; Hidetoshi Eguchi; Hiroaki Ohigashi; Osamu Ishikawa; Shingi Imaoka
Journal:  World J Surg       Date:  2006-09       Impact factor: 3.352

9.  Biliary tract invasion and obstruction by hepatocellular carcinoma: report of five cases.

Authors:  S T Lai; K T Lam; K C Lee
Journal:  Postgrad Med J       Date:  1992-12       Impact factor: 2.401

10.  Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors.

Authors:  M Y Hsieh; W Y Chang; L Y Wang; S C Chen; W L Chuang; S N Lu; D K Wu
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.